<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
70154-112-08
</NDCCode>
<PackageDescription>
240 mL in 1 BOTTLE (70154-112-08)
</PackageDescription>
<NDC11Code>
70154-0112-08
</NDC11Code>
<ProductNDC>
70154-112
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Dextromethorphan Hydrobromide, Guaifenesin, And Phenylephrine Hydrochloride
</NonProprietaryName>
<DosageFormName>
LIQUID
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20190819
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part341
</ApplicationNumber>
<LabelerName>
Monarch PCM, LLC.
</LabelerName>
<SubstanceName>
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
18; 200; 10
</StrengthNumber>
<StrengthUnit>
mg/15mL; mg/15mL; mg/15mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2020-05-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20201231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20190819
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>